
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
Elvira Scotto Reiterated (AROC) at Buy and Held Target at $22 on, Aug 7th, 2024


🞛 This publication is a summary or evaluation of another publication
Elvira Scotto of RBC Capital, Reiterated "Archrock, Inc." (AROC) at Buy and Held Target at $22 on, Aug 7th, 2024.
Elvira has made no other calls on AROC in the last 4 months.
There is 1 other peer that has a rating on AROC. Out of the 1 peers that are also analyzing AROC, 0 agree with Elvira's Rating of Hold.
This is the rating of the analyst that currently disagrees with Elvira
- Selman Akyol of "Stifel" Maintained at Strong Buy with Increased Target to $25 on, Wednesday, July 24th, 2024